Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 10 | uM | 7 | 312.50 | 61.21 | 108.00 | 1198.75 | 0.0901 | 0.1415 |
| MCF 10A | 17-AAG | 0.1 | uM | 7 | 312.50 | 61.21 | 69.00 | 1198.75 | 0.0576 | 0.0283 |
| MCF 10A | Lapatinib | 0.01 | uM | 7 | 312.50 | 61.21 | 888.00 | 1198.75 | 0.7408 | 0.8649 |
| MCF 10A | 17-AAG | 0.031623 | uM | 7 | 312.50 | 61.21 | 84.00 | 1198.75 | 0.0701 | 0.0765 |
| MCF 10A | Lapatinib | 0.1 | uM | 7 | 312.50 | 61.21 | 931.00 | 1198.75 | 0.7766 | 0.8856 |
| MCF 10A | Lapatinib | 0.031623 | uM | 7 | 312.50 | 61.21 | 1326.00 | 1198.75 | 1.1062 | 1.0476 |
| MCF 10A | Linsitinib | 3.1623 | uM | 7 | 312.50 | 61.21 | 447.00 | 1198.75 | 0.3729 | 0.5893 |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 1120.00 | 1198.75 | 0.9343 | 0.9686 | |
| MCF 10A | Erlotinib | 0.1 | uM | 7 | 312.50 | 61.21 | 1101.00 | 1198.75 | 0.9185 | 0.9608 |
| MCF 10A | Linsitinib | 0.31623 | uM | 7 | 312.50 | 61.21 | 958.00 | 1198.75 | 0.7992 | 0.8982 |
| MCF 10A | Linsitinib | 0.1 | uM | 7 | 312.50 | 61.21 | 794.00 | 1198.75 | 0.6624 | 0.8170 |
| MCF 10A | Erlotinib | 1 | uM | 7 | 312.50 | 61.21 | 277.00 | 1198.75 | 0.2311 | 0.4216 |
| MCF 10A | Linsitinib | 19.9526 | uM | 7 | 312.50 | 61.21 | 215.00 | 1198.75 | 0.1794 | 0.3401 |
| MCF 10A | Erlotinib | 0.031623 | uM | 7 | 312.50 | 61.21 | 1210.00 | 1198.75 | 1.0094 | 1.0044 |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 1142.00 | 1198.75 | 0.9527 | 0.9775 | |
| MCF 10A | 17-AAG | 3.1623 | uM | 7 | 312.50 | 61.21 | 65.00 | 1198.75 | 0.0542 | 0.0141 |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 992.00 | 1198.75 | 0.8275 | 0.9137 | |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 4.00 | 1198.75 | 0.0033 | -0.4704 | |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 2.00 | 1198.75 | 0.0017 | -0.5494 | |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 2071.00 | 1198.75 | 1.7276 | 1.2717 | |
| MCF 10A | 17-AAG | 10 | uM | 7 | 312.50 | 61.21 | 94.00 | 1198.75 | 0.0784 | 0.1051 |
| MCF 10A | 17-AAG | 0.0016596 | uM | 7 | 312.50 | 61.21 | 1923.00 | 1198.75 | 1.6042 | 1.2328 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 7 | 312.50 | 61.21 | 2040.00 | 1198.75 | 1.7018 | 1.2638 |
| MCF 10A | Erlotinib | 0.01 | uM | 7 | 312.50 | 61.21 | 1999.00 | 1198.75 | 1.6676 | 1.2531 |
| MCF 10A | 0 | uM | 7 | 312.50 | 61.21 | 2020.00 | 1198.75 | 1.6851 | 1.2586 |